This line from an article from market herald sums this trial up perfectly. Just imagine if Revascor becomes part of the litany of other treatments that are given to patients with heart disease.
https://themarketherald.com.au/mesoblast-asxmsb-shares-plummet-on-trial-results-2020-12-15/"The data from the trial means Revascor reduces mortality with existing drugs that reduce hospitalisation rates, but does not significantly impact cardiac mortality."
- Forums
- ASX - By Stock
- MSB
- Ann: Mesoblast Phase 3 Chronic Heart Failure Results
Ann: Mesoblast Phase 3 Chronic Heart Failure Results, page-326
- There are more pages in this discussion • 697 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.18 |
Change
-0.005(0.42%) |
Mkt cap ! $1.341B |
Open | High | Low | Value | Volume |
$1.18 | $1.20 | $1.14 | $10.44M | 8.934M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 45750 | $1.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 1476 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 45750 | 1.170 |
3 | 4661 | 1.165 |
3 | 105000 | 1.160 |
5 | 55881 | 1.155 |
5 | 1067107 | 1.150 |
Price($) | Vol. | No. |
---|---|---|
1.175 | 1476 | 1 |
1.180 | 25803 | 3 |
1.185 | 202720 | 3 |
1.190 | 182048 | 8 |
1.195 | 80846 | 5 |
Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.18 |
  |
Change
-0.005 ( 0.31 %) |
|||
Open | High | Low | Volume | ||
$1.18 | $1.20 | $1.14 | 1465927 | ||
Last updated 15.59pm 24/05/2024 ? |
Featured News
MSB (ASX) Chart |